eli lilly zepbound - Search News

Eli Lilly unveils $27bn US investment

CNN on MSN · 3h

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals.

The Financial Times · 3h

Eli Lilly unveils $27bn US investment as corporate America seeks to woo Trump

Eli Lilly has unveiled a $27bn investment in US manufacturing facilities as the pharmaceutical industry prepares for the threat of tariffs and mounts a charm offensive aimed at President Donald Trump’s new administration.

CNBC on MSN · 1h

Eli Lilly CEO on $27 billion investment in U.S. manufacturing expansion

CNBC’s Angelica Peebles and Eli Lilly CEO David Ricks, join 'Squawk on the Street' to discuss the company's U.S. manufacturing sites expansion, tariffs and domestic jobs.

Eli Lilly announces $27 billion investment in U.S. drug manufacturing sites

Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in the U.S., at a time when President Trump is seeking to press drugmakers to move stateside.

Eli Lilly is offering weight loss drug Zepbound

MarketWatch on MSN · 5h

Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will also be adding two new doses,

Hosted on MSN · 21h

Eli Lilly cuts prices for Zepbound weight-loss drug again

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

The Wall Street Journal on MSN · 20h

Eli Lilly to Offer Higher Doses of Obesity Drug Zepbound at Discounted Prices

Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

1don MSN

Why Eli Lilly Stock Popped Today

Eli Lilly ( LLY 2.31%) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive ...

BioPharma Dive3h

Lilly expands US manufacturing build-out with $50B target

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

1h

Eli Lilly to build 4 more manufacturing sites in US

Eli Lilly ( LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the ...

1d

Eli Lilly and Company (LLY): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years

We recently compiled a list of the 20 High Growth Mega Cap Stocks You Can Buy And Hold For Next 5 Years. In this article, we ...

24/7 Wall St. on MSN1d

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk's (NYSE:NVO) was ...

Lilly banks stockpile of oral GLP-1 drug with potential launch still more than a year away

Eli Lilly was second to the lucrative GLP-1 market for diabetes and obesity following its chief metabolic medicine rival Novo ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results